Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer

Clinical trial NCT01683994 · COMPLETED

Trial details

NCT number: NCT01683994
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2012-09-07
Primary completion: 2018-07-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.